Literature DB >> 27491911

Brugada Syndrome and the Subcutaneous Implantable Cardioverter-Defibrillator.

Louise R A Olde Nordkamp, Giulio Conte, Boudewijn R A M Rosenmöller, Joppe L F Warnaars, Hanno L Tan, Maria L Caputo, Francois Regoli, Tiziano Moccetti, Angelo Auricchio, Reinoud E Knops, Arthur A M Wilde.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27491911     DOI： 10.1016/j.jacc.2016.05.058

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

1.  Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.

Authors:  Tsukasa Kamakura; Mitsuru Wada; Kohei Ishibashi; Yuko Y Inoue; Koji Miyamoto; Hideo Okamura; Satoshi Nagase; Takashi Noda; Takeshi Aiba; Satoshi Yasuda; Kengo Kusano
Journal:  Heart Vessels       Date:  2017-05-18       Impact factor: 2.037

2.  Brugada Syndrome: Defining the Risk in Asymptomatic Patients.

Authors:  Juan Sieira; Pedro Brugada
Journal:  Arrhythm Electrophysiol Rev       Date:  2016

Review 3.  Brugada Syndrome: Evolving Insights and Emerging Treatment Strategies.

Authors:  Stephen A Duffett; Jason D Roberts
Journal:  J Innov Card Rhythm Manag       Date:  2017-02-15

4.  Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes.

Authors:  Pier D Lambiase; Lars Eckardt; Dominic A Theuns; Timothy R Betts; Andreas L Kyriacou; Elizabeth Duffy; Reinoud Knops
Journal:  Heart Rhythm O2       Date:  2020-10-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.